Brutinib has anti‐inflammatory and anti‐diabetic effects in a model of HFD‐ induced insulin resistance and diabetic nephropathy
Main Authors: | , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Wiley
2019
|
Main Authors: | , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Wiley
2019
|